{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:16Z","timestamp":1786975576865,"version":"build-2736575974"},"reference-count":12,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1001\/jamadermatol.2018.2191","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T15:54:16Z","timestamp":1539186856000},"page":"1453","source":"Crossref","is-referenced-by-count":46,"title":["Treatment of Severe Hailey-Hailey Disease With Apremilast"],"prefix":"10.1001","volume":"154","author":[{"given":"Julie","family":"Kieffer","sequence":"first","affiliation":[{"name":"Department of Dermatology, Universit\u00e9 Nice C\u00f4te d\u2019Azur, Centre Hospitalier Universitaire Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Le Duff","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Universit\u00e9 Nice C\u00f4te d\u2019Azur, Centre Hospitalier Universitaire Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Montaudi\u00e9","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Universit\u00e9 Nice C\u00f4te d\u2019Azur, Centre Hospitalier Universitaire Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chiaverini","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Universit\u00e9 Nice C\u00f4te d\u2019Azur, Centre Hospitalier Universitaire Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Lacour","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Universit\u00e9 Nice C\u00f4te d\u2019Azur, Centre Hospitalier Universitaire Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Universit\u00e9 Nice C\u00f4te d\u2019Azur, Centre Hospitalier Universitaire Nice, Nice, France"},{"name":"INSERM U1065, C3M, team 12, Universit\u00e9 Nice C\u00f4te d\u2019Azur, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"20","key":"dbr180013r1","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1007\/s00018-017-2544-7","article-title":"The role of the ATP2C1 gene in Hailey-Hailey disease.","volume":"74","author":"Deng","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"dbr180013r2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2310\/7750.2014.14037","article-title":"Remission of refractory benign familial chronic pemphigus (Hailey-Hailey disease) with the addition of systemic cyclosporine.","volume":"19","author":"Varada","year":"2015","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"dbr180013r3","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4103\/0378-6323.66597","article-title":"Benign familial pemphigus (Hailey-Hailey disease) responsive to low dose cyclosporine.","volume":"76","author":"Nanda","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"dbr180013r4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/ced.1995.20.issue-1","article-title":"Benign familial chronic pemphigus (Hailey-Hailey disease) responds to cyclosporin.","volume":"20","author":"Berth-Jones","year":"1995","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"dbr180013r5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/bjd.1991.124.issue-3","article-title":"Benign familial pemphigus responsive to cyclosporin, a possible role for cellular immunity in pathogenesis.","volume":"124","author":"Ormerod","year":"1991","journal-title":"Br J Dermatol"},{"issue":"2","key":"dbr180013r6","first-page":"49","article-title":"Hailey-Hailey disease treated with methotrexate.","volume":"6","author":"D\u2019Errico","year":"2012","journal-title":"J Dermatol Case Rep"},{"issue":"1","key":"dbr180013r7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/jdv.2009.24.issue-1","article-title":"Methotrexate for refractory Hailey-Hailey disease.","volume":"24","author":"Vilarinho","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"dbr180013r8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/0019-5154.127684","article-title":"Hailey-Hailey disease responding to thalidomide.","volume":"59","author":"Nanda","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"3","key":"dbr180013r9","doi-asserted-by":"publisher","first-page":"e0172821","DOI":"10.1371\/journal.pone.0172821","article-title":"Tissue-specific regulation of CXCL9\/10\/11 chemokines in keratinocytes: Implications for oral inflammatory disease.","volume":"12","author":"Marshall","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"dbr180013r10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","article-title":"Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease.","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"dbr180013r11","doi-asserted-by":"publisher","first-page":"906349","DOI":"10.1155\/2015\/906349","article-title":"The pharmacodynamic impact of apremilast, an oral* phosphodiesterase 4 inhibitor, on circulating levels of inflammatory biomarkers in patients with psoriatic arthritis: substudy results from a phase III, randomized, placebo-controlled trial (PALACE 1).","volume":"2015","author":"Schafer","year":"2015","journal-title":"J Immunol Res"},{"issue":"12","key":"dbr180013r12","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","article-title":"Apremilast mechanism of action and application to psoriasis and psoriatic arthritis.","volume":"83","author":"Schafer","year":"2012","journal-title":"Biochem Pharmacol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2705767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T11:10:22Z","timestamp":1544613022000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.2191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.2191","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}